An increase in 1 mg/dl of hs-CRP level calculated to increase the risk of developing NAFLD by 1.7 times as compared to controls after adjusting for significant variables associated with NAFLD. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.